Why Cancer Vaccine Research Needs Support Now More Than Ever
As featured in the Nature Index Cancer supplement, cancer vaccine research is gaining remarkable momentum globally, with particular advances in mRNA technology showing promise for reducing cancer recurrence after surgery. Despite these exciting developments highlighted by Senior Editor Bec Crew, the field faces significant challenges as funding cuts in the US raise concerns about sustaining this critical research momentum. The article reveals a tension between scientific promise and financial support that could impact the future trajectory of cancer vaccine development, a pivotal moment where strategic partnerships could make a meaningful difference in maintaining research continuity. View the full article here>>
If you are interested in supporting this vital research area through our sponsorship opportunities, contact our team today.
By partnering with us, you gain visibility among leading cancer researchers and position your brand alongside authoritative content that shapes the future of oncology.
About Nature Index supplements:
Nature Index supplements are special features published in Nature using data from the Nature Index database.
Organizations are able to feature in the supplements to communicate their prominence on a particular topic. In 2025, Nature supplement topics include Energy, Cancer, Corporate in Science (Science Inc), Research Hospitals, Immunology, Ageing, and Young Universities.
Interested in featuring in the next Nature Index supplements?
View the full 2025 calendar of Nature supplements >>
